123 related articles for article (PubMed ID: 36682146)
1. The value of second opinions on thyroid nodule management provided via direct-to-consumer telemedicine service.
Benaim E; Dudley S; Grande P; Gillespie MB
Am J Otolaryngol; 2023; 44(2):103732. PubMed ID: 36682146
[TBL] [Abstract][Full Text] [Related]
2. Malignancy risk stratification and FNA recommendations for thyroid nodules: A comparison of ACR TI-RADS, AACE/ACE/AME and ATA guidelines.
Peng JY; Pan FS; Wang W; Wang Z; Shan QY; Lin JH; Luo J; Zheng YL; Hu HT; Ruan SM; Liang JY; Xie XY; Lu MD
Am J Otolaryngol; 2020; 41(6):102625. PubMed ID: 32668355
[TBL] [Abstract][Full Text] [Related]
3. Discordance Between the American Thyroid Association and the American College of Radiology Guideline Systems for Thyroid Nodule Biopsy.
Kim E; Pudhucode R; Chen H; Lindeman B
J Surg Res; 2020 Nov; 255():469-474. PubMed ID: 32622161
[TBL] [Abstract][Full Text] [Related]
4. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Haugen BR; Alexander EK; Bible KC; Doherty GM; Mandel SJ; Nikiforov YE; Pacini F; Randolph GW; Sawka AM; Schlumberger M; Schuff KG; Sherman SI; Sosa JA; Steward DL; Tuttle RM; Wartofsky L
Thyroid; 2016 Jan; 26(1):1-133. PubMed ID: 26462967
[TBL] [Abstract][Full Text] [Related]
5. Improving Malignancy Prediction in AUS/FLUS Pediatric Thyroid Nodules with the Aid of Ultrasound.
Arora S; Khoury J; Trout AT; Chuang J
Horm Res Paediatr; 2020; 93(4):239-244. PubMed ID: 32894855
[TBL] [Abstract][Full Text] [Related]
6. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
7. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.
Gharib H; Papini E; Valcavi R; Baskin HJ; Crescenzi A; Dottorini ME; Duick DS; Guglielmi R; Hamilton CR; Zeiger MA; Zini M;
Endocr Pract; 2006; 12(1):63-102. PubMed ID: 16596732
[TBL] [Abstract][Full Text] [Related]
8. Comparison and preliminary discussion of the reasons for the differences in diagnostic performance and unnecessary FNA biopsies between the ACR TIRADS and 2015 ATA guidelines.
Wu XL; Du JR; Wang H; Jin CX; Sui GQ; Yang DY; Lin YQ; Luo Q; Fu P; Li HQ; Teng DK
Endocrine; 2019 Jul; 65(1):121-131. PubMed ID: 30830584
[TBL] [Abstract][Full Text] [Related]
9. Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.
Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Zhou F; Simsir A; Sheth S; Brandler TC
Cancer Cytopathol; 2020 Jul; 128(7):470-481. PubMed ID: 32078249
[TBL] [Abstract][Full Text] [Related]
10. Implementing Key Changes in the American Thyroid Association 2015 Thyroid Nodules/Differentiated Thyroid Cancer Guidelines Across Practice Types.
Twining CL; Lupo MA; Tuttle RM
Endocr Pract; 2018 Sep; 24(9):833-840. PubMed ID: 30308136
[TBL] [Abstract][Full Text] [Related]
11. Overview of the 2015 American Thyroid Association guidelines for managing thyroid nodules and differentiated thyroid cancer.
Matti B; Cohen-Hallaleh R
N Z Med J; 2016 Sep; 129(1441):78-86. PubMed ID: 27607088
[TBL] [Abstract][Full Text] [Related]
12. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE.
Gharib H; Papini E; Garber JR; Duick DS; Harrell RM; Hegedüs L; Paschke R; Valcavi R; Vitti P;
Endocr Pract; 2016 May; 22(5):622-39. PubMed ID: 27167915
[TBL] [Abstract][Full Text] [Related]
13. Follow-Up Strategies for Thyroid Nodules with Benign Cytology on Ultrasound-Guided Fine Needle Aspiration: Malignancy Rates of Management Guidelines Using Ultrasound Before and After the Era of the Bethesda System.
Yoon JH; Lee HS; Kim EK; Moon HJ; Park VY; Kwak JY
Thyroid; 2019 Sep; 29(9):1227-1236. PubMed ID: 31359839
[No Abstract] [Full Text] [Related]
14. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
[TBL] [Abstract][Full Text] [Related]
15. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
[TBL] [Abstract][Full Text] [Related]
16. Retrospective Application of the 2015 American Thyroid Association Guidelines for Ultrasound Classification, Biopsy Indications, and Follow-up Imaging of Thyroid Nodules: Can Improved Reporting Decrease Testing?
Mohammadi M; Betel C; Burton KR; Higgins KM; Ghorab Z; Halperin IJ
Can Assoc Radiol J; 2019 Feb; 70(1):68-73. PubMed ID: 30691566
[TBL] [Abstract][Full Text] [Related]
17. Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?
Yoo MR; Gweon HM; Park AY; Cho KE; Kim JA; Youk JH; Son EJ
PLoS One; 2015; 10(6):e0130138. PubMed ID: 26115096
[TBL] [Abstract][Full Text] [Related]
18. Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.
Manning AM; Yang H; Falciglia M; Mark JR; Steward DL
Otolaryngol Head Neck Surg; 2017 Apr; 156(4):611-615. PubMed ID: 28118554
[TBL] [Abstract][Full Text] [Related]
19. An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules.
Taccogna S; Papini E; Novizio R; D'Angelo M; Turrini L; Persichetti A; Pontecorvi A; Guglielmi R
Front Endocrinol (Lausanne); 2022; 13():1078019. PubMed ID: 36531453
[TBL] [Abstract][Full Text] [Related]
20. A 2015 Survey of Clinical Practice Patterns in the Management of Thyroid Nodules.
Burch HB; Burman KD; Cooper DS; Hennessey JV; Vietor NO
J Clin Endocrinol Metab; 2016 Jul; 101(7):2853-62. PubMed ID: 27014951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
